Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer's Disease Using Bioinformatics Analysis

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2021 Jul 1

PMID 34194312

Citations 22

Authors

Wuhan Yu

Weihua Yu

Yan Yang

Yang Lu

Affiliations

Soon will be listed here.

Abstract

Background: Alzheimer's disease (AD) is one of the major threats of the twenty-first century and lacks available therapy. Identification of novel molecular markers for diagnosis and treatment of AD is urgently demanded, and genetic biomarkers show potential prospects.

Method: We identify and intersected differentially expressed genes (DEGs) from five microarray datasets to detect consensus DEGs. Based on these DEGs, we conducted Gene Ontology (GO), performed the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, constructed a protein-protein interaction (PPI) network, and utilized Cytoscape to identify hub genes. The least absolute shrinkage and selection operator (LASSO) logistic regression was applied to identify potential diagnostic biomarkers. Gene set enrichment analysis (GSEA) was performed to investigate the biological functions of the key genes.

Result: We identified 608 consensus DEGs, several dysregulated pathways, and 18 hub genes. Sixteen hub genes dysregulated as AD progressed. The diagnostic model of 35 genes was constructed, which has a high area under the curve (AUC) value in both the validation dataset and combined dataset (AUC = 0.992 and AUC = 0.985, respectively). The model can also differentiate mild cognitive impairment and AD patients from controls in two blood datasets. Brain-derived neurotrophic factor (BDNF) and WW domain-containing transcription regulator protein 1 (WWTR1), which are associated with the Braak stage, Aβ 42 levels, and β-secretase activity, were identified as critical genes of AD.

Conclusion: Our study identified 16 hub genes correlated to the neuropathological stage and 35 potential biomarkers for the diagnosis of AD. WWTR1 were identified as candidate genes for future studies. This study deepens our understanding of the transcriptomic and functional features and provides new potential diagnostic biomarkers and therapeutic targets for AD.

Citing Articles

Comparative Analysis of Human Brain RNA-seq Reveals the Combined Effects of Ferroptosis and Autophagy on Alzheimer's Disease in Multiple Brain Regions.

Ye K, Zhao X, Liu L, Ge F, Zheng F, Liu Z Mol Neurobiol. 2024; .

PMID: 39710824 DOI: 10.1007/s12035-024-04642-2.

MIMR: Development of a Web-Based System for miRNA and mRNA Integrated Analysis.

Kim D, Ko Y Int J Mol Sci. 2024; 25(21).

PMID: 39519370 PMC: 11546888. DOI: 10.3390/ijms252111819.

Targeted co-expression networks for the study of traits.

Gomez-Pascual A, Rocamora-Perez G, Ibanez L, Botia J Sci Rep. 2024; 14(1):16675.

PMID: 39030261 PMC: 11271532. DOI: 10.1038/s41598-024-67329-7.

SCG5 and MITF may be novel markers of copper metabolism immunorelevance in Alzheimer's disease.

Zhuang X, Xia Y, Liu Y, Guo T, Xia Z, Wang Z Sci Rep. 2024; 14(1):13619.

PMID: 38871989 PMC: 11176367. DOI: 10.1038/s41598-024-64599-z.

A review and analysis of key biomarkers in Alzheimer's disease.

Zhang Z, Liu X, Zhang S, Song Z, Lu K, Yang W Front Neurosci. 2024; 18:1358998.

PMID: 38445255 PMC: 10912539. DOI: 10.3389/fnins.2024.1358998.

References

Sorbi S, Forleo P, Tedde A, Cellini E, Ciantelli M, Bagnoli S . Genetic risk factors in familial Alzheimer's disease. Mech Ageing Dev. 2001; 122(16):1951-60. DOI: 10.1016/s0047-6374(01)00308-6. View

Solarski M, Wang H, Wille H, Schmitt-Ulms G . Somatostatin in Alzheimer's disease: A new Role for an Old Player. Prion. 2017; 12(1):1-8. PMC: 5871028. DOI: 10.1080/19336896.2017.1405207. View

Connor B, Dragunow M . The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev. 1998; 27(1):1-39. DOI: 10.1016/s0165-0173(98)00004-6. View

Deiana M, Dalle Carbonare L, Serena M, Cheri S, Parolini F, Gandini A . New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration. Cells. 2018; 7(11). PMC: 6262450. DOI: 10.3390/cells7110220. View

Huang R, Huang J, Cathcart H, Smith S, Poduslo S . Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet. 2007; 44(2):e66. PMC: 2598055. DOI: 10.1136/jmg.2006.044883. View

Tanzi R, Bertram L . Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. 2005; 120(4):545-55. DOI: 10.1016/j.cell.2005.02.008. View

Jiang S, Tang L, Zhao N, Yang W, Qiu Y, Chen H . A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer's Disease. Front Aging Neurosci. 2016; 8:171. PMC: 4941795. DOI: 10.3389/fnagi.2016.00171. View

Braun D, Kalinin S, Feinstein D . Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease. ASN Neuro. 2017; 9(2):1759091417696161. PMC: 5415058. DOI: 10.1177/1759091417696161. View

Stopa E, Tanis K, Miller M, Nikonova E, Podtelezhnikov A, Finney E . Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis. Fluids Barriers CNS. 2018; 15(1):18. PMC: 5977762. DOI: 10.1186/s12987-018-0102-9. View

10.

Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R . Missing value estimation methods for DNA microarrays. Bioinformatics. 2001; 17(6):520-5. DOI: 10.1093/bioinformatics/17.6.520. View

11.

Leek J, Johnson W, Parker H, Jaffe A, Storey J . The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012; 28(6):882-3. PMC: 3307112. DOI: 10.1093/bioinformatics/bts034. View

12.

Ren Z, Yu J, Wu Z, Si W, Li X, Liu Y . MicroRNA-210-5p Contributes to Cognitive Impairment in Early Vascular Dementia Rat Model Through Targeting Snap25. Front Mol Neurosci. 2018; 11:388. PMC: 6243094. DOI: 10.3389/fnmol.2018.00388. View

13.

Banwait J, Bastola D . Contribution of bioinformatics prediction in microRNA-based cancer therapeutics. Adv Drug Deliv Rev. 2014; 81:94-103. PMC: 4277182. DOI: 10.1016/j.addr.2014.10.030. View

14.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

15.

Boettcher J, Hartman K, Ladror D, Qi Z, Woods W, George J . Membrane-induced folding of the cAMP-regulated phosphoprotein endosulfine-alpha. Biochemistry. 2008; 47(47):12357-64. DOI: 10.1021/bi801450t. View

16.

de Oliveira-Junior L, Santos F, Goulart L, Ueira-Vieira C . Epitope Fingerprinting for Recognition of the Polyclonal Serum Autoantibodies of Alzheimer's Disease. Biomed Res Int. 2015; 2015:267989. PMC: 4568325. DOI: 10.1155/2015/267989. View

17.

Zetterberg H, Andreasen N, Blennow K . Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease. Neurosci Lett. 2004; 367(2):194-6. DOI: 10.1016/j.neulet.2004.06.001. View

18.

Khan A, Ali A, Junaid M, Liu C, Kaushik A, Cho W . Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network. BMC Syst Biol. 2018; 12(Suppl 4):39. PMC: 5998885. DOI: 10.1186/s12918-018-0563-0. View

19.

Wang E, Zhu H, Wang X, Gower A, Wallack M, Blusztajn J . Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model. J Alzheimers Dis. 2016; 56(1):47-61. PMC: 5331853. DOI: 10.3233/JAD-160677. View

20.

Marmigere F, Givalois L, Rage F, Arancibia S, Tapia-Arancibia L . Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus. 2003; 13(5):646-55. DOI: 10.1002/hipo.10109. View